iShares U.S. Pharmaceutical ETF (IHE): Price and Financial Metrics ETF
IHE Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $63.02 | 52-week high | $69.56 |
| Prev. close | $63.10 | 52-week low | $55.36 |
| Day low | $62.78 | Volume | 67,600 |
| Day high | $63.21 | Avg. volume | 73,143 |
| 50-day MA | $66.92 | Dividend yield | 3.01% |
| 200-day MA | $62.28 |
IHE Stock Price Chart Interactive Chart >
iShares U.S. Pharmaceutical ETF (IHE) ETF Bio
The investment objective of the iShares Dow Jones U.S. Pharmaceutical Index Fund ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector.
IHE ETF Info
| Issuer | BlackRock iShares |
| Expense Ratio | 0.39% |
| Underlying Index | Dow Jones U.S. Select Pharmaceuticals Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 653.02M |
| Net Asset Value (NAV) | $63.09 |
| Options? | Yes |
| Total Holdings | 39 |
IHE Top Holdings
| Symbol | Company | % of Total |
| LLY | ELI LILLY | 23.32% |
| JNJ | JOHNSON & JOHNSON | 22.07% |
| MRK | MERCK & CO INC | 4.92% |
| PFE | PFIZER INC | 4.6% |
| RPRX | ROYALTY PHARMA PLC CLASS A | 4.5% |
| VTRS | VIATRIS INC | 4.44% |
| BMY | BRISTOL MYERS SQUIBB | 4.4% |
| CTLT | CATALENT INC | 4.31% |
| ZTS | ZOETIS INC CLASS A | 4.06% |
| ITCI | INTRA CELLULAR THERAPIES INC | 3.06% |
IHE Price Returns
| 1-mo | -6.18% |
| 3-mo | 0.32% |
| 6-mo | 10.25% |
| 1-year | 5.13% |
| 3-year | 9.06% |
| 5-year | 40.84% |
| YTD | 2.39% |
| 2023 | 0.91% |
| 2022 | -4.87% |
| 2021 | 13.07% |
| 2020 | 13.66% |
| 2019 | 15.47% |
IHE Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||